Glidewell Laboratories Names Dr. Neil Park Director Of Clinical Affairs

NEWPORT BEACH, Calif., Jan. 19, 2016 /PRNewswire/ -- GlidewellLaboratories, industry-leading provider of dental products, implant solutions and lab services, announced today the hire of Dr. Neil Park as their Director of Clinical Affairs, a new position created to oversee the clinical aspects of product research and development. In addition to coordinating the activities of the company's clinical staff, Dr. Park will help guide the company's training and education efforts to meet the needs of dentists and enhance knowledge and awareness of new techniques, materials and procedures.

Photo -

After graduating from Temple University School of Dentistry, Dr. Park practiced as a general dentist for 12 years before moving on to an accomplished career in the dental implant industry. This included a 19-year stint with Nobel Biocare during which he managed the company's continuing education programs and university relationships, and helped bring several key implant systems and restorative solutions to market. As part of this effort, Dr. Park was key in developing and implementing a predoctoral implant curriculum in universities throughout North America.

In 2010 Dr. Park transitioned from Nobel Biocare to ClearChoice Dental Implant Centers, the foremost provider of implant treatment in the U.S. There, he led efforts to increase patient acceptance of full-arch implant treatment.

Most recently, Dr. Park was at the helm of professional development at Zimmer Biomet Dental, where he oversaw practitioner education programs and managed the company's relationships with universities and national dental associations. Having joined yet another industry leader in Glidewell Laboratories, Dr. Park is eager to aid the company's efforts to improve treatment outcomes and expand patient access to care.

"Glidewell Laboratories has a unique perspective as a manufacturer of dental implants and prosthetics because of our long history supporting doctors in planning and restoring cases. We have a staff of clinicians that test the effectiveness of techniques, products and treatment protocols," Dr. Park recently noted. "Dentists want to know that their restorations will be durable, esthetic and serve the patient well. Our one-of-a-kind clinical operation allows the opportunity to develop implants and prostheses that accomplish just that and have been verified using licensed dentists and real patients."

"This capability really doesn't exist anywhere else," he continued. "We generate a great deal of useful clinical data from a large number of patients, and we utilize that research to guide doctors in their choice of materials and techniques. Doctors want confidence in the restorations they prescribe, and 45 years as a market-leading dental lab has given us a great idea of what materials and implant designs will work well in the hands of dentists."

In addition to overseeing the clinical aspect of product research, development and evaluation, Dr. Park's accomplished background in doctor training and education will inform the company's efforts to help practitioners incorporate the latest procedures and technologies. Now that most dental school graduates have received some basic training in diagnosing, treatment planning and restoring implant cases a development he fostered during his tenure with Nobel Biocare Dr. Park recognizes that the role of implant manufacturers in continuing education has shifted. "Glidewell Laboratories understands that the best way to serve dentists is by leveraging technology, innovation and education to improve the results and value they can deliver for patients, and I look forward to contributing to that effort."

Dr. Park will be instrumental to the accelerating rollout of the Hahn Tapered Implant System, which was released in 2015 and designed by Dr. Jack Hahn, a pioneer in implantology and developer of the original tapered implant. "Dr. Hahn has been placing and designing implants for quite some time and has seen what has worked and what hasn't firsthand. His latest implant blends clinically proven features and innovations inspired by the four-decades-plus he's been practicing implant dentistry. I'm excited to help get the word out on how this system can get practitioners even better results."

Glidewell Laboratories is a privately owned corporation that has more than 45 years of history as a provider of high-quality restorations and implant solutions to dental practitioners nationwide. Its CAD/CAM processing capabilities are recognized as among the most advanced in the industry. To view its large selection of clinical videos, CE courses, and products and services, visit the Glidewell Laboratories website,

To view the original version on PR Newswire, visit:

SOURCE Glidewell Laboratories

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

U.K.-based alpha-synuclein biotech Wren will partner with Japanese pharma Eisai to seek out new ways of targeting neuro disorders.

As Moderna continues to drip-feed the latest data from its late-stage COVID-19 vaccine effort, it has updated the shot’s efficacy figure.

Two research teams have discovered drug combinations that may make it possible to translate CAR-T cell therapies to solid tumors.